repurposed nilotinib (University of California San Diego)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namerepurposed nilotinib (University of California San Diego)
Drug Alias Namenilotinib
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiscoidin domain receptors inhibitorsStem cell growth factor receptor inhibitorsSonic Hedgehog Homolog inhibitors +[6] 
TargetsStem cell growth factor receptorSmoothened receptorBcr-Abl tyrosine kinase +[6] 
Therapy Area/IndicationsMedulloblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San Diego
Inactive CompaniesN/A
Active IndicationsMedulloblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A